Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Merit Medical Systems Inc Issues FY 2013 Guidance Below Analysts' Estimates


Thursday, 25 Apr 2013 04:01pm EDT 

Merit Medical Systems Inc announced that for fiscal 2013, it expects revenues to be in the range of $445-$455 million, an increase of approximately 13-15%, compared to revenues of $394.3 million for the year ended December 31, 2012. Also, based on information currently available to Merit's management, Merit estimates that, absent non-recurring transactions, Merit's GAAP earnings per share for fiscal 2013 to be in the range of $0.30-$0.36, compared to GAAP earnings per share of $0.46 for the year ended December 31, 2012, and non-GAAP earnings per share of $0.50-$0.56. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $461 million and EPS of $0.64 for fiscal 2013. 

Company Quote

14.86
0.06 +0.41%
22 Jul 2014